Chiron Behring GmbH & Co.
Records under this name other than patents Chiron Behring GmbH & Co. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Chiron Behring GmbH & Co.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,329,536 | Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture Formerly held Term ended Term ended Mar 7, 2023 · High confidence | Term ended | Term ended Mar 7, 2023 | High confidence |
| US 6,656,720 | Animal Cells and Processes for the Replication of Influenza Viruses Formerly held Term ended Ended no later than Apr 17, 2021 · Low confidence | Term ended | Ended no later than Apr 17, 2021 | Low confidence |
| US 7,772,386 | Identification of specific differentially expressed antigens Formerly held Term ended Term ended Jan 28, 2020 · From the USPTO record | Term ended | Term ended Jan 28, 2020 | From the USPTO record |
| US 6,300,102 | Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins Term ended Term ended Mar 10, 2019 · From the USPTO record | Term ended | Term ended Mar 10, 2019 | From the USPTO record |
| US 6,455,298 | Animal cells and processes for the replication of influenza viruses Formerly held Term ended Term ended Sep 29, 2018 · From the USPTO record | Term ended | Term ended Sep 29, 2018 | From the USPTO record |
| US 4,271,147 | Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same Term ended Term ended no later than Jun 2, 2001 · Low confidence | Term ended | Term ended no later than Jun 2, 2001 | Low confidence |
| US 4,275,165 | Process for isolating hepatitis A-virus Term ended Term ended no later than Jun 23, 2001 · Low confidence | Term ended | Term ended no later than Jun 23, 2001 | Low confidence |
| US 4,891,226 | Pharmaceutical which can be administered nasally, a process for its preparation, and its use Term ended Term ended no later than Jan 2, 2010 · Low confidence | Term ended | Term ended no later than Jan 2, 2010 | Low confidence |
| US 5,194,587 | Malaria-specific DNA sequences, expression products thereof, and the use thereof Term ended Term ended no later than Mar 16, 2013 · Low confidence | Term ended | Term ended no later than Mar 16, 2013 | Low confidence |
| US 5,393,523 | Plasmodium falciparum vaccine comprising a recombinant histidine-rich protein-HRP-II Term ended Term ended no later than Feb 28, 2015 · Low confidence | Term ended | Term ended no later than Feb 28, 2015 | Low confidence |